PRODUCT DESCRIPTION The machine specify diameter and mass ball fall on the foam specimen from certain height, calculate the percentage between maximum drop height and rebound height, indicate foam resilience by spring rate. It uses a microprocessor to control, LCD display. GENERL SPECIFICATIONS Packaging Dimensions: (WxDxH) 680*470*860mm Power supply source: single-phase, AC220V�±10%, 50/60Hz (can be appointed) Gross Weight: 40kg APPLICATION STANDARDS: ASTM D 3574, ISO 8307, SEC N3296 STANDARD FEATURES Drop height 500±0.5%mm Drop ball Diameter: 16±0.05 mm, mass 16.8g ± 1.5 g Accuracy
COVID 19 Antibody Test Kits COVID 19 NIV Test Kits
New Arrival Pass Management Kiosk for Temperature Measurement & Face Recognition, Specially designed for COVID-19/Coronavirus. Introduction ONT-SV-1081D, pass management vertical module of temperature measurement & face recognition uses Rockchip RK3288 / RK3399 / Qualcomm MSM8953 high-performance hardware platform, equipped with industrial-class binocular camera, live face recognition technology and infrared thermal imaging module to support face-with-mask identify. It also supports expansion of various peripherals such as ID card readers, fingerprint readers, etc., which can be applied to gate passages and attendance system to achieve safe and efficient access control for personnel. Features 1. 8-inch IPS full-view LCD display. 2. Industrial-class appearance, waterproof and dustproof design which is stable and reliable. 3. Supports 30,000 face database. The 1: 1 comparison recognition rate is more than 99.7%, the 1: N comparison recognition rate is more than 96.7%@0.1% misrecognition rate, and the live detection accuracy rate is 98.3%@1% misrejection rate. Face recognition pass speed is less than 1 second. 4. Supports accurate face recognition and comparison while wearing a mask. 5. Using industrial-grade binocular wide dynamic camera, night infrared and LED dual photo flood lamp. 6. Support processors with strong performance: Rockchip RK3288 quad-core processor, Rockchip RK3399 six-core processor and Qualcomm MSM8953 octa-core processor. 7. Supports human body temperature detection and temperature display. The best temperature detection distance is 0.5 meters. The longest distance at which body temperature can be measured is 1 meter. The measurement error is plus or minus 0.5 â??. 8. It only takes a few seconds for detection, and supports automatic alarm for body temperature abnormality. 9. Attendance temperature measurement data is exported in real time. 10. Supports various peripheral expansions such as ID card reader, fingerprint reader, IC card reader, two-dimensional code reader, etc. 11. The documentation is complete and supports secondary development. 12. Support system level, APP offline level, APP + background network level multiple API docking.
Immune colloidal gold technique kit This product is used to qualitative detection of the presence of IgM and/or IgG antibody to SARS-CoV-2 in Human serum, plasma and whole blood. The common symptoms are fever, cough, polypnea and anhelation when infected with SARS-CoV-2. In more serious cases, infection may cause pneumonia, severe acute respiratory syndrome, renal failure and even death. Coronavirus can be excreted through respiratory secretions and transmitted by air droplet. Infection may be caused by saliva, sneeze and contact.
General Specification 1. Main Features  Operationg SyetemWindow 7 Monitor 12.1 inch LED high-resolution monitor Scanning ModeB, B/B, 4B, B/M, M, 3D Image Reconstruction KeyboardBack-lit Silicone Keyboard (option) Cine LoopUp to 1024 frames Gain0-255dB TGC8 segment Scanning DepthUp to 240mm Dynamic Range20-150dB Pseudo-color40, or customized Body Marking140 Focus4 Magnification0.8-6.0 Probe Connector2 LanguageChinese/English/Spanish Matching PrinterLaser/Vedio/Inkjet/Thermal printer Peripheral PortUSB, DICOM3.0, RS232, VGA, VCR, PAL-D Measurement & CalculationB-mode: Distance, Perimeter, Area, Volume, Angle, Histogram, Cross Section, Hip Joint Angle M-mode: Heart Rate, Time, Gradient Image Processing TechnologiesTHI, Pre-process, Post-process, Dynamic Range, Contrast, Frame Correlation, Average Line, Edge Enhancement, Black-white Change over, Gray-scale Transformation&Adjustment, Brightness, Gamma Correction  2. Applications Abdominal(Liver, Gallbladder, Spleen, Kidney, Pancreas) Gynecology(Uterus, Cervix Uterus, Endometrium, Ovary, Ovarian Follicle, Hydatoncus, Enclosed Mass) Obstetric(AC, BPD, CRL, FL, THD, GS, OFD, HUMERUS, TIDIA, ULNA, HC, TAD, APTD, FTA, AFI, Analytic report of fetus and the growth curve) Cardiology(LV, LV Function, Aorta, Mitral, Valve) Urology(Left Renal Volume, Right Renal Volume, RUV, Prostate kidney) Small Parts(Ophthalmology, Thyroid, Jaw and Face) 3. Standard Configuration Main system unit, 3.5MHz Convex probe, Lithium battery, Power adapter, Carrier suitcase, User manual and disc 4. Optional Items Biopsy Bracket 5. Probes Selection 3.5 MHz Convex Probe (3.5-14MHz variable frequency ) 7.5 MHz Linear Probe (3.5-14MHz variable frequency ) 7.5 MHz Transvaginal Probe (3-10MHz variable frequency) 5.0 MHz Micro-Convex Probe (2-6MHz variable frequency) 7.5 MHz Rectal Probe(80 elements) 6. Advanced Technologies PC platform Full Digital Ultrasonic Kernel Engine One Touch Optimizer Tissue Harmonic Imaging 3D Imaging Reconstruction DICOM 3.0 Packaging & Delivery Packaging Details: Aluminum Case+Box Package Net Weight: 2.5kg Gross Weight: 7kg Package Size: 370*295*170mm Delivery Time: 5-10 working days Warranty Two years for main unit (One year warranty for probes) Please let us know your specific request. We would like to recommend you the most suitable model based on your information.
Mini alcohol breathalyzer With Bluetooth With mouthpieces Support transfer data to PC
INTENDED USE A rapid animal diagnostic test kit for simple antigen detection that can check the presence of coronavirus antigens in dog feces and diagnose the sample with a simple operation within 10 minutes. Symptom of a disease The virus that enters the dogs mouth reaches the small intestines through the stomach, multiplies in the mucous membrane, secretes toxic substances, and destroys the intestinal mucous membrane. The main symptoms of coronavirus are enteritis or diarrhea. However, it is not fatal and shows symptoms such as vomiting and dehydration.
INTENDED USE A rapid animal diagnostic test kit for simple antigen detection that can check the presence of parvovirus antigens in dog feces and diagnose the sample with a simple operation within 10 minutes. Symptom of a disease It is infected by contact or oral cavity through the feces of an infected dog. Symptoms are diarrhea and are highly contagious diseases. The parvovirus first develops within 48 to 72 hours. In dogs infected for more than eight weeks, it usually causes vomiting, stinky gray diarrhea or bloody excrement, rapid weakness, and loss of appetit
MastoCheck is a blood test that can easily screen for breast cancer at an early stage. Breast cancer is diagnosed early by substituting the quantitative values of three types of protein biomarkers in the blood, which are closely related to breast cancer, into a unique, patented algorithm. An innovative and convenient test method that detects early breast cancer with an accuracy of 92% (based on the patent) by using only a very small amount of blood. Bertis has developed multiple markers that can detect early breast cancer with an accuracy of 92% through identification of multiple proteins that are expressed sensitively in early-stage breast cancer and combination of certain proteins that demonstrated high accuracy and reproducibility among these combinations. DEVELOPMENT PROCESS: - MASTOCHECK was developed by a team led by Professor Dong-Young Noh, a world-renowned authority on breast cancer, of Seoul National University. - After analyzing approximately 600,000 proteins and selecting 3 markers exhibiting optimal accuracy, the highest accuracy was obtained by adding Bertis�¢?? own algorithm that enhances accuracy. - After several years of repeated validation work, a medical device product license was obtained from the MFDS in January 2019. To date (as of September 2023), MASTOCHECK has been introduced to about 400 hospitals and screening institutions nationwide, with priority given to large screening institutions.
Proteomics-based early diagnosis determines the presence of disease by identifying proteins that are specifically expressed in diseases and using these as biomarkers to measure the quantitative values of the relevant proteins in blood. Proteomics analysis has been assessed as highly likely to be used as a universal primary screening method because analysis can be performed even with trace samples, such as a few drops of blood. High diagnostic accuracy : Quantitative values of biomarkers are measured and entered in a unique algorithm with applied AI. Convenience : No burden of inconvenience caused due to the use of a separate diagnostic device other than blood sampling Efficiency: Provides diagnosis opportunities to more people in situations where personnel and devices are limited
Exo-PASS Exosomes contain proteins, lipids, nucleic acids, and metabolites, and can be easily enriched from biofluids, providing very valuable information for early detection and monitoring of diseases. The Ministry of Food and Drug Safety requires RNA, lipid and proteomic analyses in its guidelines for the development of exosome therapeutics, and PASS provides these analyses in an all-in-one package. Exosome RNA Sequencing: PASS enables rapid and efficient isolation of RNAs and profiling of exosome nucleic acids using qRT-PCR and novel sequencing methods. Exosome Lipidomics: We perform high-reliability and high-sensitivity analysis through an ultra-high-performance tool (UPLC, Orbitrap Exploris 480 MS) and lipid analysis experts who have been producing and interpreting analysis data for many years. Exosome Proteomics: PASS offers and performs quantification analysis that meets customer needs based on the unique expertise in exosome protein extraction. We provide reliable results through deep profiling of exosome proteome and a specialized data library. Our world-class bioinformatics research team at Bertis reviews and interprets pan-omics data (RNA/Lipid) to support in-depth research.
PASS is an analysis solution optimized for academia and pharma research. The proprietary solution was derived from proven technology and innovation embedded in Mastocheck, a proteomics-based early cancer diagnostics approved by Ministry of Food and Drug Safety (MFDS). Bertis developed the PASS solution based on its pan-omics, bioinformatics, and artificial intelligence (AI) technologies. We provide a variety of analyzes for proteomic analysis, biomarker discovery and verification, new drug development, clinical process development, etc. PASS is a platform for integrative analysis of pan-omics data, based on our proven and reliable bioinformatics analysis capabilities. Our team consists of experienced scientists with an extensive track record of research achievements spanning more than a decade in mass spectrometry-based proteomics. Bertis possesses the core expertise and proprietary technology for pan-omics (multi-omics) analysis to provide customized solutions in all fields where omics data analysis is applicable. With PASS, you can leverage Bertis scientific resources and cutting-edge tools to advance your research projects and goals, from the design stage to the interpretation and visualization of bioinformatics analysis results.
Proteomics-based Early diagnosis using multiple markers provides a quick and accurate solution for early diagnosis of major diseases by utilizing multiple proteomic biomarker-based blood tests. Early diagnostic solutions BERTIS has commercialized MASTOCHECK, the worlds first proteomics-based blood test solution for early diagnosis of breast cancer, and clinical trials are being conducted on biomarkers for various cancers. Ultimately, these technologies are being used to continually expand the pipeline to allow dozens of diseases to be diagnosed with a single blood test.
Biomarker Diseases Diagnosis Blood Tests Proteomics-based early diagnosis Provides a quick and accurate solution for early diagnosis of major diseases by utilizing multiple proteomic biomarker-based blood tests. Advantages of proteomics-based early diagnosis: Proteomics-based early diagnosis determines the presence of disease by identifying proteins that are specifically expressed in diseases and using these as biomarkers to measure the quantitative values of the relevant proteins in blood. Proteomics analysis has been assessed as highly likely to be used as a universal primary screening method because analysis can be performed even with trace samples, such as a few drops of blood.
PC-PASS Protein Characterization Analysis Protein Characterization (Physicochemical property of proteins) structure analysis using mass spectrometry provides results that meet the requirements of the FDA, the MFDS and other regulatory authorities regarding novel therapies or biosimilars. Based on basic amino acid analysis (full sequencing), we perform post-translational modification (PTM) analysis, which is important for protein potency and stability. In this regard, we can perform test methods based on design of experiment (DOE) statistical methodology and deliver documents to be submitted to regulatory authorities. Protein identification and quantification : Structural analysis of all types of protein therapeutics, including monoclonal antibodies (mAbs), antibody-drug conjugates (ADCs), and enzymes - Full Length-Amino acids sequencing Peptide identification of each peak through peptide mapping (MS spectrum confirmation, MS/MS spectral analysis with 100% AA matches) - Improved N- and C-terminal sequencing of proteins Post-translational modification (PTM) : More reliable results based on design of experiment (DOE) statistical methodology to perform the experiments systematically and analyze data efficiently - Disulfide bond analysis ID Total possible lankage analysis - Deamidation identification and quantification - Phosphorylation identification and quantification , phospho-proteomic analysis - Other functional modifications Glycomics : Single protein analysis and research of protein complexes with glycosylation closely related to biological function and toxicity as well as structural stability of proteins - Glycosylation site determination - Glycan profiling - Site-specific glycan identification and quantification - Glycomics research with glycan enrichment
One step, rapid immunochromatographic assay for detectionof NS1Ag of all serotypes of Dengue virus in human serum orplasmaDetection of infection prior to sero - conversionDetects all serotypes (DEN-1,DEN-2,DEN-3, DEN-4)Specimen volume : 90 - 100 ul of Serum/PlasmaNo sample preparation requiredResult interpretation time: 20 minsSensitivity :> 95%. Specificity : =95%
Testing 1
Test Test Test Test Test Test
test test test test test test test test test test test test test test test test test test test test test test test test test test test
Accu check active test strip and performa strips.
